Joan Blade Creixenti
AuthID: R-00K-NRV
1
TÃTULO: Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study
AUTORES: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Creixenti, Joan Blade; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre H.; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; ...Mais
PUBLICAÇÃO: 2022, FONTE: BLOOD, VOLUME: 140
AUTORES: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Creixenti, Joan Blade; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre H.; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; ...Mais
PUBLICAÇÃO: 2022, FONTE: BLOOD, VOLUME: 140
INDEXADO EM: 
WOS
WOS